Literature DB >> 20822735

Pertussis outbreak in northwest Ireland, January - June 2010.

A S Barret1, A Ryan, A Breslin, L Cullen, A Murray, J Grogan, S Bourke, S Cotter.   

Abstract

We report a community pertussis outbreak that occurred in a small town located in the northwest of Ireland. Epidemiological investigations suggest that waning immunity and the absence of a booster dose during the second year of life could have contributed to the outbreak. The report also highlights the need to reinforce the surveillance of pertussis in Ireland and especially to improve the clinical and laboratory diagnosis of cases.

Mesh:

Substances:

Year:  2010        PMID: 20822735

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  11 in total

1.  Interactions of Bordetella pertussis adenylyl cyclase toxin CyaA with calmodulin mutants and calmodulin antagonists: comparison with membranous adenylyl cyclase I.

Authors:  Dominik Schuler; Carolin Lübker; Gerald H Lushington; Wei-Jen Tang; Yuequan Shen; Mark Richter; Roland Seifert
Journal:  Biochem Pharmacol       Date:  2012-01-13       Impact factor: 5.858

Review 2.  Licensed pertussis vaccines in the United States. History and current state.

Authors:  Nicola P Klein
Journal:  Hum Vaccin Immunother       Date:  2014-11-06       Impact factor: 3.452

3.  Respiratory tract infections during the 2011 Mycoplasma pneumoniae epidemic.

Authors:  N Reinton; L Manley; T Tjade; A Moghaddam
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-25       Impact factor: 3.267

4.  Booster vaccination of pre-school children with reduced-antigen-content diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine co-administered with measles-mumps-rubella-varicella vaccine: a randomized, controlled trial in children primed according to a 2 + 1 schedule in infancy.

Authors:  Giuseppe Ferrera; Mario Cuccia; Gabriele Mereu; Giancarlo Icardi; Gianni Bona; Susanna Esposito; Federico Marchetti; Marc Messier; Sherine Kuriyakose; Karin Hardt
Journal:  Hum Vaccin Immunother       Date:  2012-02-13       Impact factor: 3.452

5.  Pertussis resurgence in Toronto, Canada: a population-based study including test-incidence feedback modeling.

Authors:  David N Fisman; Patrick Tang; Tanya Hauck; Susan Richardson; Steven J Drews; Donald E Low; Frances Jamieson
Journal:  BMC Public Health       Date:  2011-09-07       Impact factor: 3.295

6.  Needle size for vaccination procedures in children and adolescents.

Authors:  Paul V Beirne; Sarah Hennessy; Sharon L Cadogan; Frances Shiely; Tony Fitzgerald; Fiona MacLeod
Journal:  Cochrane Database Syst Rev       Date:  2018-08-09

7.  Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis.

Authors:  Davide Valentini; Giovanni Ferrara; Reza Advani; Hans O Hallander; Markus J Maeurer
Journal:  BMC Immunol       Date:  2015-07-01       Impact factor: 3.615

8.  Pertussis surveillance and control: exploring variations and delays in testing, laboratory diagnostics and public health service notifications, the Netherlands, 2010 to 2013.

Authors:  Jeanne Heil; Henriëtte L G Ter Waarbeek; Christian J P A Hoebe; Peter H A Jacobs; Dirk W van Dam; Thera A M Trienekens; Jochen W L Cals; Inge H M van Loo; Nicole H T M Dukers-Muijrers
Journal:  Euro Surveill       Date:  2017-07-13

9.  Estimation of the underlying burden of pertussis in adolescents and adults in Southern Ontario, Canada.

Authors:  Ashleigh A McGirr; Ashleigh R Tuite; David N Fisman
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

10.  Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An open, phase III, non-randomized, multi-center study.

Authors:  Martina Kovac; Lusiné Kostanyan; Narcisa Mesaros; Sherine Kuriyakose; Meera Varman
Journal:  Hum Vaccin Immunother       Date:  2018-05-10       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.